The Global Rate Rally… And All The Headlines In The Weight-Loss Drug Space 3/19/26
Rates across the world are climbing as central banks raise inflation warnings. How yesterday’s Fed decision sets up a potential rate *hike* at the bank’s June meeting, and when the recent jump in yields could finally hit the equity market. Plus, Eli Lilly’s latest trial data, Novo’s FDA approval, and the patent…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from CNBC's "Fast Money"
See all episodes →Meta’s Rally Keeps Rocking… And A Major AI Safety Warning 9/24/26
U.S. 10-Year Yield Hits 19-Year High… And The Ripple Effects From Meta’s Muse 9/23/26
Meta’s Muse Ripple Effects… And A Coiled Spring In Google 9/22/26
Similar episodes from other shows
More like CNBC's "Fast Money" →
Rate Hike Odds Surge As GDP Forecasts Collapse – Ep. 232
CNBC Special: The Fed Decision – March 11, 2022
The Rate Hike Wall Street Expected
Hike or hold: Investors split ahead of Fed decision
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.